Thus, understanding the mechanism of tPA-mediated PDGF-CC activation within the NVU has important clinical implications and may accelerate the development of adjuvant treatments that could reduce the risk of hemorrhagic complications associated with thrombolytic therapy for ischemic stroke. The gene discussed is PLAT; the disease is ischemic stroke.